CN Patent

CN102264725B — 蛋白激酶抑制剂

Assigned to Eli Lilly and Co · Expires 2014-04-16 · 12y expired

What this patent protects

本发明提供了式(I)化合物或其可药用盐，其用于治疗细胞增殖性疾病。

USPTO Abstract

本发明提供了式(I)化合物或其可药用盐，其用于治疗细胞增殖性疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN102264725B
Jurisdiction
CN
Classification
—
Expires
2014-04-16
Drug substance claim
No
Drug product claim
No
Assignee
Eli Lilly and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.